O

Oropharma

BE0431.268.730

Marge brute
€ 21K ↓ 59% 2025 Total € 260K
Résultats
€ 19K ↓ 62% 2025 Total € 1.69M
EBITDA
€ 20K ↓ 57% 2025 Total € 2.35M
EBIT
€ 20K ↓ 57% 2025 Total € 2.34M
Bénéfice net
€ 19K ↓ 62% 2025 Total € 1.69M
Capex
€ 0 ↓ 100% 2014 Total € 0
Total de l'actif
€ 352K ↓ 38% 2025
Fonds propres
€ 197K ↑ 11% 2025
Dettes
€ 155K ↓ 61% 2025
Cashflow
€ 19K ↓ 62% 2025 Total € 1.69M
Working capital
€ 197K ↑ 11% 2025
Current ratio
2.27 ↑ 57% 2025
Quick ratio
1.55 ↑ 29% 2025
Working capital ratio
2.27 ↑ 57% 2025
Dettes
€ 155K ↓ 61% 2025
Dettes à court terme
€ 155K ↓ 61% 2025
Dettes / EBITDA
7.75 ↓ 9% 2025
Solvabilité
56.0% ↑ 24.9 pt 2025
Interest Coverage Ratio
535 ↓ 95% 2015
Rentabilité brute
9.8% ↓ 18.8 pt 2025
Rentabilité nette
9.8% ↓ 18.8 pt 2025
Return On Assets (ROA)
5.47 ↓ 39% 2025
Return On Equity (ROE)
9.76 ↓ 66% 2025
Crédit client
43.11 ↑ 47% 2017
Crédit fournisseur
33.79 ↓ 29% 2017
Days Sales Outstanding (DSO)
43.11 ↑ 47% 2017
Days Sales of Inventory (DSI)
11.94 ↑ 49% 2017
Impôts
€ 70K ↑ 237% 2020 Total € 600K
Dividendes
€ 100K ↓ 67% 2020 Total € 2.93M
Taux de distribution
402.9% ↑ 76.3 pt 2020